Artia Global Partners LP 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Artia Global Partners LP disclosed 47 US equity positions worth $526.0m in its Q2 2026 13F filing. The largest position was ABVX at 13.1% of the reported book, followed by INSM and TRVI. Against the Q1 2026 filing, it opened 7 new positions, added to 10 and reduced 3 among the top 47 holdings.
What did Artia Global Partners LP own in Q2 2026? Top 47 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | ABVX ABIVAX SA | Healthcare | 13.1% | $68.8m | 516,447 | -14% | reduced |
| 2 | INSM INSMED INC | Healthcare | 11.9% | $62.8m | 589,052 | -6% | reduced |
| 3 | TRVI TREVI THERAPEUTICS INC | Healthcare | 7.8% | $41.2m | 2,210,852 | 10% | added |
| 4 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 6.9% | $36.1m | 517,315 | 862% | added |
| 5 | RVMD REVOLUTION MEDICINES INC | Healthcare | 6.6% | $34.7m | 185,390 | 48% | added |
| 6 | ARGX ARGENX SE | Healthcare | 5.2% | $27.6m | 29,739 | 0% | held |
| 7 | ALKS ALKERMES PLC | Healthcare | 4.5% | $23.5m | 448,964 | – | new |
| 8 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 3.7% | $19.3m | 339,033 | 380% | added |
| 9 | AZN ASTRAZENECA PLC | Healthcare | 3.5% | $18.7m | 98,376 | 3% | added |
| 10 | NEWAMSTERDAM PHARMA COMPANY | 3.2% | $17.1m | 503,936 | 0% | held | |
| 11 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 3.0% | $15.9m | 162,990 | 0% | held |
| 12 | DGX QUEST DIAGNOSTICS INC | Healthcare | 2.6% | $13.8m | 65,122 | 60% | added |
| 13 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 2.2% | $11.4m | 144,376 | 0% | held |
| 14 | EYPT EYEPOINT INC | Healthcare | 2.1% | $11.0m | 767,098 | 0% | held |
| 15 | ALMS ALUMIS INC | Healthcare | 1.5% | $7.8m | 278,546 | -14% | reduced |
| 16 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.3% | $7.1m | 180,731 | 0% | held |
| 17 | CELC CELCUITY INC | Healthcare | 1.2% | $6.2m | 59,316 | 281% | added |
| 18 | CYTK CYTOKINETICS INC | Healthcare | 1.1% | $6.0m | 70,700 | 334% | added |
| 19 | MRK MERCK & CO INC | Healthcare | 1.1% | $6.0m | 46,700 | 0% | held |
| 20 | RAPP RAPPORT THERAPEUTICS INC | 1.1% | $5.8m | 138,508 | 0% | held | |
| 21 | JNJ JOHNSON & JOHNSON | Healthcare | 1.1% | $5.7m | 22,600 | 0% | held |
| 22 | GH GUARDANT HEALTH INC | Healthcare | 1.1% | $5.7m | 38,100 | – | new |
| 23 | ABSI ABSCI CORPORATION | Healthcare | 1.0% | $5.4m | 464,444 | – | new |
| 24 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 1.0% | $5.3m | 96,285 | 0% | held |
| 25 | SION SIONNA THERAPEUTICS INC | Healthcare | 1.0% | $5.3m | 119,741 | 0% | held |
| 26 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.9% | $4.7m | 17,740 | – | new |
| 27 | ROIV ROIVANT SCIENCES LTD | Healthcare | 0.9% | $4.6m | 129,800 | 0% | held |
| 28 | PALI PALISADE BIO INC | Healthcare | 0.8% | $4.2m | 1,992,367 | 0% | held |
| 29 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 0.8% | $4.0m | 98,800 | 51% | added |
| 30 | BIIB BIOGEN INC | Healthcare | 0.8% | $4.0m | 18,437 | 0% | held |
| 31 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.7% | $3.9m | 65,000 | 0% | held |
| 32 | BLTE BELITE BIO INC | Healthcare | 0.7% | $3.8m | 24,989 | 0% | held |
| 33 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.7% | $3.7m | 137,800 | 0% | held |
| 34 | PROK PROKIDNEY CORP | 0.7% | $3.7m | 1,806,939 | 0% | held | |
| 35 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.7% | $3.7m | 72,100 | 245% | added |
| 36 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.6% | $3.2m | 33,400 | – | new |
| 37 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.5% | $2.8m | 22,951 | 0% | held |
| 38 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 0.5% | $2.7m | 5,000 | 0% | held |
| 39 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.5% | $2.7m | 38,407 | 0% | held |
| 40 | KINIKSA PHARMACEUTICALS INTL | 0.4% | $1.9m | 29,200 | 0% | held | |
| 41 | CMPX COMPASS THERAPEUTICS INC | 0.2% | $839.2k | 383,200 | – | new | |
| 42 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.2% | $837.0k | 2,500 | 0% | held |
| 43 | KOD KODIAK SCIENCES INC | Healthcare | 0.1% | $663.1k | 17,019 | 0% | held |
| 44 | TENX TENAX THERAPEUTICS INC | 0.1% | $612.3k | 42,080 | 0% | held | |
| 45 | NUVALENT INC | 0.1% | $605.1k | 4,900 | 0% | held | |
| 46 | PEPG PEPGEN INC | Healthcare | 0.1% | $369.6k | 205,324 | 0% | held |
| 47 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 0.1% | $355.1k | 4,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.